Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.
Increasing magnetic field is known to give improvements in signal-to-noise-ratio (SNR) and spectral resolution. To investigate this, spectra from different subjects were examined using two clinical MR instruments operating at 1.5T and 3T respectively.
|Study Design:||Observational Model: Case Control
Time Perspective: Cross-Sectional
|Official Title:||In Vivo Proton MR Spectroscopy of Brain Metastases Obtained at 1,5T and 3T.|
|Study Start Date:||November 2003|
|Study Completion Date:||June 2005|
|Primary Completion Date:||December 2004 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00184353
|Norwegian University of Science and Technology|
|Trondheim, Norway, N-7489|
|Study Director:||Steinar Lundgren, MD PhD||Cancer Clinic, St.Olavs Hospital Trondheim University Hospital|
|Study Chair:||Ingrid S Gribbestad, PhD||Norwegian University of Science and Technology, Faculty of Medicine|